Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Activist Investor Takes Stake in CVS -- Update

share with twitter share with LinkedIn share with facebook
share via e-mail
11/25/2019 | 04:19pm EST

By Corrie Driebusch

Activist investor Starboard Value LP has taken a stake in CVS Health Corp. and held talks with the drugstore-and-insurance giant's management, according to people familiar with the matter.

The stake appears to be relatively small and the people said the talks, held recently, are amicable. How much Starboard currently owns and what it has discussed with the company couldn't be learned. But Starboard is one of the top activist-investment firms and its presence in a stock usually causes a company to sit up and take notice.

CVS shares have been on a roller-coaster ride since the company acquired health insurer Aetna Inc. for nearly $70 billion almost a year ago. The deal married CVS's sprawling drugstore network and pharmacy-benefit manager with one of the nation's largest health insurers.

The stock fell sharply after the Woonsocket, R.I., company in February issued a downbeat earnings projection for the year due to challenges in its pharmacy-benefits and long-term-care businesses. The shares went on to rebound sharply as the company reported a string of unexpectedly strong financial results, and research analysts have taken a more favorable view.

Shares of CVS rival Walgreens Boots Alliance Inc. have slumped about 25% in the past year as revenue from prescription-drug sales slows and competition from online retailers grows. Walgreens shares have been buoyed in recent weeks by reports of private-equity interest. No such deal appears to be imminent, people familiar with the matter say.

CVS stock, at around $76, is little changed in the past year compared with a big gain in the S&P 500 index. CVS's market capitalization currently stands at about $100 billion.

Some investors have privately expressed frustration over rising costs from CVS's Omnicare drug-distribution business, the lack of a clear plan for a successor to Chief Executive Larry Merlo and the large size of its 16-member board -- a legacy of the Aetna deal.

Bankers and lawyers who advise companies facing threats from activists say the investors are increasingly taking stakes in large targets and engaging with management instead of immediately going public with their demands. More often, the investors and their targets are finding common ground. Sometimes the campaigns never surface publicly.

Starboard has a record of ushering in change at companies ranging from eBay Inc. to Darden Restaurants Inc. Earlier this year, it urged eBay to exit businesses unrelated to its core marketplace after taking a stake in the San Jose, Calif., company. On Monday, eBay agreed to sell its StubHub ticketing business for more than $4 billion.

Starboard didn't report a stake in CVS in its latest quarterly filing with the Securities and Exchange Commission. Those filings are delayed -- the latest revealed the New York hedge fund's holdings as of Sept. 30 -- and some information may be omitted as investors can receive confidential treatment if they are in the process of building a position.

--Sharon Terlep contributed to this article.

Write to Corrie Driebusch at corrie.driebusch@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION -0.25% 59.18 Delayed Quote.-20.14%
DJ INDUSTRIAL -1.39% 25409.36 Delayed Quote.-5.54%
NASDAQ 100 0.30% 8461.834492 Delayed Quote.1.17%
NASDAQ COMP. 0.01% 8567.367588 Delayed Quote.-0.08%
S&P 500 -0.82% 2954.22 Delayed Quote.-3.54%
share with twitter share with LinkedIn share with facebook
share via e-mail
02/24WALL STREET STOCK EXCHANGE : Dow sheds 800 points as pandemic fears grip Wall St..
02/24CVS HEALTH : Aetna Whole Health Launches In Atlanta Providing Fully Insured And ..
02/18CVS HEALTH : Management's Discussion and Analysis of Financial Condition and Res..
02/14CVS HEALTH : RespireRx Pharmaceuticals CEO Issues Progress and Status Report
02/13CVS HEALTH : Aetna Medicaid Launches New Approach To Integrated Care Supporting ..
02/13CVS Reaps Benefits of Aetna Deal -- WSJ
02/13CVS HEALTH : pharmacy business lifted by high prices
02/12CVS HEALTH : Business Highlights
02/12Health Care Up As Investors Hedge On Chances Of Coronavirus Cure -- Health Ca..
More news
Financials (USD)
Sales 2020 263 B
EBIT 2020 15 728 M
Net income 2020 7 302 M
Debt 2020 55 418 M
Yield 2020 3,38%
P/E ratio 2020 10,6x
P/E ratio 2021 9,53x
EV / Sales2020 0,50x
EV / Sales2021 0,46x
Capitalization 77 376 M
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 84,23  $
Last Close Price 59,18  $
Spread / Highest target 84,2%
Spread / Average Target 42,3%
Spread / Lowest Target 20,0%
EPS Revisions
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President